Global Xenotransplantation Market By Animal Type (Pig, Rabbit, Baboon, Others), By Xeno Products (Organs, Tissues, Cells), By Organs (Kidney, Liver, Heart, Cornea, Others), By End Users (Transplants Center, Hospitals, Others), By Region, Competition Forecast & Opportunities, 2027
Global xenotransplantation market is expected to grow at a CAGR of 8.52% and reach USD 1289.11 million in 2031. This can be attributed to the rise in surgeries and improved understanding of immune system. Chronic kidney disease is a major public health issue in the United States, affecting over eight million people. When kidney function reaches a certain point, patients have end-stage renal disease and require dialysis or transplantation to live. More than 340,000 people are currently on dialysis, with 106,000 new patients added in 2019. Over 140,000 people had a functioning kidney transplant in the last 20 years, the prevalence of end-stage renal disease in these two populations has tripled. In 2020, medicare expenditures for end-stage renal disease are expected to exceed USD 28 billion.
Rise in Surgeries Increases the Demand for Xenotransplantation
Some of the factors that are likely to drive the growth of the xenotransplantation market include an increase in the volume of organ transplantation surgeries, an increase in the occurrence of chronic diseases, an increase in investment for the development of advanced and technical products, and an increase in the geriatric population. Changing lifestyles among the growing population, on the other hand, would increase numerous opportunities, which is expected to lead to a growth of xenotransplantation market throughout the forecast period.
Deceased donor kidney transplant was performed on 10,659 patients, while a live donor kidney transplant was performed on 6,432 patients. However, there are currently over 74,000 people on the national waiting list for a deceased donor kidney transplant. Even though the number of kidney transplants performed each year is increasing, the waiting list continues to grow. Every day, twelve people die while waiting for a kidney transplant.
Increasing demand for tissue and organ transplantation fuel the demand for xenotransplantation
The global demand for organ transplantation has increased rapidly over the last decade due to an increase in the incidence of vital organ failure, rising success, and greater improvement in post-transplant outcome. However, the lack of sufficient organs for transplantation to meet current demand has resulted in major organ shortage crises. As a result, the number of patients on transplant waiting lists and the number of patients dying while on the waiting list has increased significantly.
Improved understanding of immune system to drive global xenotransplantation market
Organ transplantation is one of the success stories of the second half of the twentieth century. Indeed, its success has resulted in the referral of an increasing number of patients, resulting in a scarcity of donor organs. Our better understanding of the immune system and the immune rejection process has resulted in the development of therapies that, in theory, will overcome the robust immune responses associated with xenogeneic tissue transplantation. In the coming years, human clinical trials using animal cells and organs to treat some of these diseases are expected to become a reality.
The introduction of advanced tissue products such as DeNovo NT also boost the xenotransplantation market
DeNovo NT Graft is a juvenile cartilage implant that is particulate and used to repair articular cartilage damage. Its purpose is to give surgeons an early-intervention option for articular cartilage repair. The DeNovo NT Graft is a single-stage procedure for treating articular cartilage defects in a variety of anatomical applications such as the knee, ankle, hip, shoulder, and elbow. DeNove having high technological advancement to treat the cases for transplantation.. Since, tissue transpIantation has been made very easy with the help of this technology and also provide relief to the adult patients suffering from cartilage or muscular problems, as a result, boosting the xenotransplantation market worldwide.
Market Segmentation
The global xenotransplantation market is segmented based on animal type, xeno product, organs, end users, region, and company. Based on animal type, the global xenotransplantation market can be split into pig, baboon, rabbit, and others. Based on xeno product, it can be further categorized into organs, tissues, and cells. Based on organs, the global xenotransplantation, market can be segmented into kidney, liver, heart, cornea, and others. Based on end-user, the market is segmented into transplant center, hospitals, and others. Regionally, the global xenotransplantation market can be categorized into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America dominates the overall global xenotransplantation market with United States having the biggest market. The United States xenotransplantation market is expected to grow at a CAGR of 8.97% and reach 427.39 million in 2031.
Company Profiles
Major companies in the market are Novartis AG, Accord Healthcare, Pfizer, Inc, F. Hoffmann-La Roche Ltd., Terumo Medical Corporation, Transonic, Astellas Pharma, Inc., Preservation Solutions, Inc. Bio Med Pvt. Ltd., and TransMedic, Pte. Ltd. Major players operating in the market are following strategies such as mergers and acquisitions, new therapy, among others, in order to stay competitive and have an edge over other players in the market.
Report Scope:
In this report, global xenotransplantation market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
- Global Xenotransplantation Market, By Animal Type:
- Pig
- Baboon
- Rabbit
- Others
- Global Xenotransplantation Market, By Xeno Product:
- Organs
- Tissues
- Cells
- Global Xenotransplantation Market, By Organs:
- Kidney
- Liver
- Heart
- Cornea
- Others
- Global Xenotransplantation Market, By End User:
- Hospitals
- Transplant Centers
- Others
- Global Xenotransplantation Market, By Region:
- North America
Canada
Mexico
- Europe
France
Spain
Switzerland
Italy
- Asia-Pacific
Japan
South Korea
Australia
India
- South America
Argentina
Colombia
- Middle East & Africa
Saudi Arabia
South Africa
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in global Xenotransplantation market.
Company Information
- Detailed analysis and profiling of additional market players (up to five).
- 1. Product Overview
- 2. Research Methodology
- 3. Executive Summary
- 4. Impact of COVID-19 on Global Xenotransplantation Market
- 5. Voice of Customer
- 5.1. Xenotransplantation Awareness
- 5.2. Factors Contributing Switch to Xenotransplantation
- 5.3. Preference, By Animal Type
- 5.4. Barriers to Adoption of Xenotransplantation
- 6. Clinical Trial Analysis
- 7. Patent Analysis
- 8. Successful Xenotransplantation Case Studies
- 9. Global Xenotransplantation Market Outlook
- 9.1. Market Size & Forecast
- 9.1.1. By Value
- 9.2. Market Share & Forecast
- 9.2.1. By Animal Type (Pig, Rabbit, Baboon, Others)
- 9.2.2. By Xeno Product (Organs, Tissues, Cells)
- 9.2.2.1. By Organs (Kidney, Liver, Heart, Cornea, Others)
- 9.2.3. By End User (Hospitals, Transplant Centers, Others)
- 9.2.4. By Region
- 9.3. Product Market Map
- 10. North America Xenotransplantation Market Outlook
- 10.1. Market Size & Forecast
- 10.1.1. By Value
- 10.2. Market Share & Forecast
- 10.2.1. By Animal Type (Pig, Rabbit, Baboon, Others)
- 10.2.2. By Xeno Product (Organs, Tissues, Cells)
- 10.2.2.1. By Organs (Kidney, Liver, Heart, Cornea, Others)
- 10.2.3. By End User (Hospitals, Transplant Centers, Others)
- 10.2.4. By Country
- 10.3. Policy & Regulatory Landscape
- 10.4. North America: Country Analysis
- 10.4.1. United States Xenotransplantation Market Outlook
- 10.4.1.1. Market Size & Forecast
- 10.4.1.1.1. By Value
- 10.4.1.2. Market Share & Forecast
- 10.4.1.2.1. By Animal Type
- 10.4.1.2.2. By Xeno Product
- 10.4.1.2.3. By End User
- 10.4.2. Mexico Xenotransplantation Market Outlook
- 10.4.2.1. Market Size & Forecast
- 10.4.2.1.1. By Value
- 10.4.2.2. Market Share & Forecast
- 10.4.2.2.1. By Animal Type
- 10.4.2.2.2. By Xeno Product
- 10.4.2.2.3. By End User
- 10.4.3. Canada Xenotransplantation Market Outlook
- 10.4.3.1. Market Size & Forecast
- 10.4.3.1.1. By Value
- 10.4.3.2. Market Share & Forecast
- 10.4.3.2.1. By Animal Type
- 10.4.3.2.2. By Xeno Product
- 10.4.3.2.3. By End User
- 11. Europe Xenotransplantation Market Outlook
- 11.1. Market Size & Forecast
- 11.1.1. By Value
- 11.2. Market Share & Forecast
- 11.2.1. By Animal Type (Pig, Rabbit, Baboon, Others)
- 11.2.2. By Xeno Product (Organs, Tissues, Cells)
- 11.2.2.1. By Organs (Kidney, Liver, Heart, Cornea, Others)
- 11.2.3. By End User (Hospitals, Transplant Centers, Others)
- 11.2.4. By Country
- 11.3. Policy & Regulatory Landscape
- 11.4. Europe: Country Analysis
- 11.4.1. Germany Xenotransplantation Market Outlook
- 11.4.1.1. Market Size & Forecast
- 11.4.1.1.1. By Value
- 11.4.1.2. Market Share & Forecast
- 11.4.1.2.1. By Animal Type
- 11.4.1.2.2. By Xeno Product
- 11.4.1.2.3. By End User
- 11.4.2. France Xenotransplantation Market Outlook
- 11.4.2.1. Market Size & Forecast
- 11.4.2.1.1. By Value
- 11.4.2.2. Market Share & Forecast
- 11.4.2.2.1. By Animal Type
- 11.4.2.2.2. By Xeno Product
- 11.4.2.2.3. By End User
- 11.4.3. Spain Xenotransplantation Market Outlook
- 11.4.3.1. Market Size & Forecast
- 11.4.3.1.1. By Value
- 11.4.3.2. Market Share & Forecast
- 11.4.3.2.1. By Animal Type
- 11.4.3.2.2. By Xeno Product
- 11.4.3.2.3. By End User
- 11.4.4. Switzerland Xenotransplantation Market Outlook
- 11.4.4.1. Market Size & Forecast
- 11.4.4.1.1. By Value
- 11.4.4.2. Market Share & Forecast
- 11.4.4.2.1. By Animal Type
- 11.4.4.2.2. By Xeno Product
- 11.4.4.2.3. By End User
- 11.4.5. Italy Xenotransplantation Market Outlook
- 11.4.5.1. Market Size & Forecast
- 11.4.5.1.1. By Value
- 11.4.5.2. Market Share & Forecast
- 11.4.5.2.1. By Animal Type
- 11.4.5.2.2. By Xeno Product
- 11.4.5.2.3. By End User
- 12. Asia-Pacific Xenotransplantation Market Outlook
- 12.1. Market Size & Forecast
- 12.1.1. By Value
- 12.2. Market Share & Forecast
- 12.2.1. By Animal Type (Pig, Rabbit, Baboon, Others)
- 12.2.2. By Xeno Product (Organs, Tissues, Cells)
- 12.2.2.1. By Organs (Kidney, Liver, Heart, Cornea, Others)
- 12.2.3. By End User (Hospitals, Transplant Centers, Others)
- 12.2.4. By Country
- 12.3. Policy & Regulatory Landscape
- 12.4. Asia-Pacific: Country Analysis
- 12.4.1. China Xenotransplantation Market Outlook
- 12.4.1.1. Market Size & Forecast
- 12.4.1.1.1. By Value
- 12.4.1.2. Market Share & Forecast
- 12.4.1.2.1. By Animal Type
- 12.4.1.2.2. By Xeno Product
- 12.4.1.2.3. By End User
- 12.4.2. India Xenotransplantation Market Outlook
- 12.4.2.1. Market Size & Forecast
- 12.4.2.1.1. By Value
- 12.4.2.2. Market Share & Forecast
- 12.4.2.2.1. By Animal Type
- 12.4.2.2.2. By Xeno Product
- 12.4.2.2.3. By End User
- 12.4.3. South Korea Xenotransplantation Market Outlook
- 12.4.3.1. Market Size & Forecast
- 12.4.3.1.1. By Value
- 12.4.3.2. Market Share & Forecast
- 12.4.3.2.1. By Animal Type
- 12.4.3.2.2. By Xeno Product
- 12.4.3.2.3. By End User
- 12.4.4. Japan Xenotransplantation Market Outlook
- 12.4.4.1. Market Size & Forecast
- 12.4.4.1.1. By Value
- 12.4.4.2. Market Share & Forecast
- 12.4.4.2.1. By Animal Type
- 12.4.4.2.2. By Xeno Product
- 12.4.4.2.3. By End User
- 12.4.5. Australia Xenotransplantation Market Outlook
- 12.4.5.1. Market Size & Forecast
- 12.4.5.1.1. By Value
- 12.4.5.2. Market Share & Forecast
- 12.4.5.2.1. By Animal Type
- 12.4.5.2.2. By Xeno Product
- 12.4.5.2.3. By End User
- 13. South America Xenotransplantation Market Outlook
- 13.1. Market Size & Forecast
- 13.1.1. By Value
- 13.2. Market Share & Forecast
- 13.2.1. By Animal Type (Pig, Rabbit, Baboon, Others)
- 13.2.2. By Xeno Product (Organs, Tissues, Cells)
- 13.2.2.1. By Organs (Kidney, Liver, Heart, Cornea, Others)
- 13.2.3. By End User (Hospitals, Transplant Centers, Others)
- 13.2.4. By Country
- 13.3. Policy & Regulatory Landscape
- 13.4. South America: Country Analysis
- 13.4.1. Brazil Xenotransplantation Market Outlook
- 13.4.1.1. Market Size & Forecast
- 13.4.1.1.1. By Value
- 13.4.1.2. Market Share & Forecast
- 13.4.1.2.1. By Animal Type
- 13.4.1.2.2. By Xeno Product
- 13.4.1.2.3. By End User
- 13.4.2. Argentina Xenotransplantation Market Outlook
- 13.4.2.1. Market Size & Forecast
- 13.4.2.1.1. By Value
- 13.4.2.2. Market Share & Forecast
- 13.4.2.2.1. By Animal Type
- 13.4.2.2.2. By Xeno Product
- 13.4.2.2.3. By End User
- 13.4.3. Colombia Xenotransplantation Market Outlook
- 13.4.3.1. Market Size & Forecast
- 13.4.3.1.1. By Value
- 13.4.3.2. Market Share & Forecast
- 13.4.3.2.1. By Animal Type
- 13.4.3.2.2. By Xeno Product
- 13.4.3.2.3. By End User
- 14. Middle East and Africa Xenotransplantation Market Outlook
- 14.1. Market Size & Forecast
- 14.1.1. By Value
- 14.2. Market Share & Forecast
- 14.2.1. By Animal Type (Pig, Rabbit, Baboon, Others)
- 14.2.2. By Xeno Product (Organs, Tissues, Cells)
- 14.2.2.1. By Organs (Kidney, Liver, Heart, Cornea, Others)
- 14.2.3. By End User (Hospitals, Transplant Centers, Others)
- 14.2.4. By Country
- 14.3. Policy & Regulatory Landscape
- 14.4. MEA: Country Analysis
- 14.4.1. Egypt Xenotransplantation Market Outlook
- 14.4.1.1. Market Size & Forecast
- 14.4.1.1.1. By Value
- 14.4.1.2. Market Share & Forecast
- 14.4.1.2.1. By Animal Type
- 14.4.1.2.2. By Xeno Product
- 14.4.1.2.3. By End User
- 14.4.2. Saudi Arabia Xenotransplantation Market Outlook
- 14.4.2.1. Market Size & Forecast
- 14.4.2.1.1. By Value
- 14.4.2.2. Market Share & Forecast
- 14.4.2.2.1. By Animal Type
- 14.4.2.2.2. By Xeno Product
- 14.4.2.2.3. By End User
- 14.4.3. South Africa Xenotransplantation Market Outlook
- 14.4.3.1. Market Size & Forecast
- 14.4.3.1.1. By Value
- 14.4.3.2. Market Share & Forecast
- 14.4.3.2.1. By Animal Type
- 14.4.3.2.2. By Xeno Product
- 14.4.3.2.3. By End User
- 14.4.4. South Africa Xenotransplantation Market Outlook
- 14.4.4.1. Market Size & Forecast
- 14.4.4.1.1. By Value
- 14.4.4.2. Market Share & Forecast
- 14.4.4.2.1. By Animal Type
- 14.4.4.2.2. By Xeno Product
- 14.4.4.2.3. By End User
- 15. Market Dynamics
- 15.1. Drivers
- 15.2. Challenges
- 16. Market Trends & Developments
- 17. SWOT Analysis: Global Xenotransplantation Market
- 18. Competitive Landscape (Immunosuppressant Providers for the process of Xenotransplantation)
- 18.1. Novartis AG
- 18.2. Accord Healthcare
- 18.3. Pfizer, Inc.
- 18.4. F. Hoffmann-La Roche Ltd.
- 18.5. Terumo Medical Corporation
- 18.6. Transonic
- 18.7. Astellas Pharma, Inc.
- 18.8. Preservation Solutions, Inc
- 18.9. Bio Med Pvt. Ltd.
- 18.10. TransMedic, Pte. Ltd.
- 19. Strategic Recommendations
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook